查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1684476

药物滥用检测服务市场：全球产业分析、规模、份额、成长、趋势和预测（2025-2032 年）

Drug of Abuse Testing Services Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 250 Pages | 商品交期: 2-5个工作天内

价格
简介目录

重要考察

  • 药物滥用检测服务市场规模：37.573 亿美元（2025 年）
  • 预计市场金额：55.581亿美元（2032年）
  • 全球市场成长率：5.8%（2025年至2032年的复合年增长率）

药物滥用检测服务市场-报告范围

药物滥用检测服务在职场安全、执法、医疗保健和康復中心等各个领域的非法药物消费检测中发挥着至关重要的作用。这些服务利用各种测试方法，包括尿液、血液、头髮、唾液和汗水分析，以识别管制物质的存在，包括麻醉品、兴奋剂和鸦片类药物。推动市场发展的因素包括药物滥用率的上升、政府监管的严格性以及职场药物测试计划需求的不断增长。快速筛检和基于实验室的确认测试等检测技术的进步进一步推动了市场成长。

市场成长动力

全球药物滥用检测服务市场受到药物成瘾率上升和监管力度加强等多种因素的推动。政府倡导无毒职场的倡议以及交通、国防和医疗等领域的严格政策正在推动对检测服务的需求。此外，移动式药物检测设备和基于人工智慧的结果分析等技术进步正在提高检测的准确性和效率。人们对药物滥用对健康和社会影响的认识不断提高，进一步推动了市场扩张。

市场限制

儘管成长前景看好，但市场仍面临隐私问题以及与职场和公共场所药物测试相关的法律问题等挑战。此外，先进检测服务的高成本以及快速筛检测试出现错误的可能性也阻碍了其采用。此外，不同国家有不同的药物测试法律，这给服务供应商带来了监管复杂性。应对这些挑战需要开发具有成本效益的测试解决方案、监管标准化和加强意识计划。

市场机会

由于技术创新、刑事鑑定的使用日益增多以及家庭药物检测套组的普及，药物滥用检测服务市场正在提供巨大的成长机会。即时药物检测技术的发展和区块链在安全资料管理方面的整合为市场扩张提供了新的可能性。医疗保健组织、执法机构和研究机构之间的合作将进一步加强市场成长。此外，线上药物检测服务和远端医疗咨询的普及将提高使用者的可近性和便利性。

该报告研究了全球药物滥用检测服务市场，并对市场动态进行了详细分析，包括成长动力、趋势、机会和挑战。

目录

第一章执行摘要

第二章 市场概况

  • 市场范围/分类
  • 市场定义/范围/限制

第三章 市场背景

  • 市场动态
  • 情境预测
  • 机会图分析
  • 产品生命週期分析
  • 投资可行性矩阵
  • PESTLE分析、波特分析法
  • 监管格局
  • 母市场展望：按地区

第 4 章全球药物滥用检测服务市场分析（2019-2032 年）

  • 市场规模表现分析（2019-2024）
  • 当前和未来市场规模预测（2025-2032）
    • 与前一年同期比较趋势分析
    • 绝对商机分析

5. 全球药物滥用检测服务市场按药物类型分析（2019-2032 年）

  • 简介/主要发现
  • 依药物类型分類的市场规模表现分析（2019-2024）
  • 按药物类型分類的当前和未来市场规模分析及预测（2025-2032 年）
    • 酒精
    • 大麻
    • 古柯碱
    • 阿片类药物
    • 安非他命、甲基安非他命
    • LSD
    • 其他药物类型
  • 按药物类型分類的与前一年同期比较成长趋势分析（2019-2024）
  • 按药物类型分類的绝对商机分析（2025-2032 年）

6. 全球药物滥用检测服务市场区域分析（2019-2032）

  • 介绍
  • 市场规模表现分析：按地区（2019-2024）
  • 目前市场规模分析及各区域预测（2025-2032）
    • 北美洲
    • 拉丁美洲
    • 欧洲
    • 亚太地区
    • 中东和非洲
  • 按地区分析市场吸引力

7. 北美药物滥用检测服务市场分析（按国家/地区）（2019-2032 年）

8. 拉丁美洲药物滥用检测服务市场分析（按国家/地区）（2019-2032 年）

9. 欧洲药物滥用检测服务市场各国分析（2019-2032）

第 10 章亚太地区药物滥用检测服务市场国家分析（2019-2032 年）

第 11 章。中东和非洲药物滥用检测服务市场按国家分析（2019-2032 年）

第十二章主要国家药物滥用检测服务市场分析

  • 美国
  • 加拿大
  • 巴西
  • 墨西哥
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 俄罗斯
  • 中国
  • 日本
  • 印度
  • 韩国
  • 澳洲
  • 南非
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 以色列

第十三章市场结构分析

  • 竞争仪錶板
  • 竞争基准
  • 主要企业市场占有率分析

第十四章 竞争分析

  • 衝突详情
    • Quest Diagnostics, Inc.
    • Abbott Laboratories
    • Clinical Reference Laboratory, Inc.
    • Laboratory Corporation of America Holdings
    • Cordant Health Solutions
    • Legacy Medical Services, LLC.
    • DrugScan
    • Omega Laboratories, Inc.
    • Psychemedics Corporation
    • Mayo Clinic Laboratories

第 15 章 使用的假设与缩写

第十六章调查方法

简介目录
Product Code: PMRREP33256

Persistence Market Research has recently published an in-depth analysis of the global drug of abuse testing services market, offering a detailed evaluation of key market dynamics, including drivers, trends, opportunities, and challenges. The report provides exclusive data and statistical insights that highlight the expected growth trajectory of the drug of abuse testing services market from 2025 to 2032.

Key Insights:

  • Drug of Abuse Testing Services Market Size (2025E):US$ 3,757.3 Mn
  • Projected Market Value (2032F): US$ 5,558.1 Mn
  • Global Market Growth Rate (CAGR 2025 to 2032): 5.8%

Drug of Abuse Testing Services Market - Report Scope

Drug of abuse testing services play a critical role in detecting illicit drug consumption across various sectors, including workplace safety, law enforcement, healthcare, and rehabilitation centers. These services utilize a range of testing methods, including urine, blood, hair, saliva, and sweat analysis, to identify the presence of narcotics, stimulants, opioids, and other controlled substances. The market is driven by increasing substance abuse rates, stringent government regulations, and the growing demand for workplace drug testing programs. Advancements in testing technologies, such as rapid screening and lab-based confirmatory tests, further enhance market growth.

Market Growth Drivers

The global drug of abuse testing services market is driven by several key factors, including rising drug addiction rates and increased regulatory enforcement. Government initiatives promoting drug-free workplaces and stringent policies in sectors such as transportation, defense, and healthcare drive the demand for testing services. Additionally, technological advancements, including portable drug testing devices and AI-based result analysis, improve testing accuracy and efficiency. Growing awareness about the health and social consequences of drug abuse further supports market expansion.

Market Restraints

Despite the promising growth prospects, the market faces challenges such as privacy concerns and legal issues related to drug testing in workplaces and public settings. The high cost of advanced testing services and potential inaccuracies in rapid screening tests also hinder adoption. Furthermore, variations in drug testing laws across different countries create regulatory complexities for service providers. Addressing these challenges requires the development of cost-effective testing solutions, standardized regulations, and enhanced public awareness programs.

Market Opportunities

The drug of abuse testing services market presents significant growth opportunities fueled by technological innovations, expanding forensic testing applications, and the increasing adoption of home-based drug testing kits. The development of real-time drug detection technologies and the integration of blockchain for secure data management offer new possibilities for market expansion. Collaborations between healthcare organizations, law enforcement agencies, and research institutions further strengthen market growth. Additionally, the increasing availability of online drug testing services and telehealth consultations enhances accessibility and convenience for users.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the drug of abuse testing services market globally?
  • Which testing methods and services are most widely used for drug detection?
  • How are technological advancements shaping the competitive landscape of the market?
  • Who are the key players contributing to the market, and what strategies are they employing?
  • What are the emerging trends and future prospects in the drug of abuse testing services market?

Competitive Intelligence and Business Strategy

Leading players in the global drug of abuse testing services market, including Quest Diagnostics, LabCorp, Abbott Laboratories, and Thermo Fisher Scientific, focus on innovation, service expansion, and strategic collaborations to gain a competitive edge. These companies invest in R&D to develop high-accuracy drug testing solutions, including multiplex testing panels and automated screening systems. Partnerships with government agencies, corporate clients, and healthcare providers facilitate market penetration. Additionally, efforts to enhance regulatory compliance and introduce digital solutions for seamless test result reporting further strengthen the competitive landscape.

Key Companies Profiled:

  • Quest Diagnostics
  • Abbott Laboratories
  • Cordant Health Solutions
  • Omega Laboratories
  • Mayo Clinic Laboratories
  • Air Methods
  • ALPHASTAR
  • Clinical Reference Laboratory, Inc.
  • Laboratory Corporation of America Holdings
  • Cordant Health Solutions
  • Legacy Medical Services, LLC
  • DrugScan
  • Psychemedics Corporation

Market Segments Covered in Drug of Abuse Testing Services Market Analysis

By Drug Type

  • Alcohol
  • Cannabis/Marijuana
  • Cocaine
  • Opioids
  • Amphetamine & Methamphetamine
  • LSD
  • Other Drug Types

By Region

  • North America
  • Latin America
  • Europe
  • APAC
  • MEA

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand-side Trends
  • 1.3. Supply-side Trends
  • 1.4. Technology Roadmap Analysis
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Market Background

  • 3.1. Market Dynamics
    • 3.1.1. Drivers
    • 3.1.2. Restraints
    • 3.1.3. Opportunity
    • 3.1.4. Trends
  • 3.2. Scenario Forecast
    • 3.2.1. Demand in Optimistic Scenario
    • 3.2.2. Demand in Likely Scenario
    • 3.2.3. Demand in Conservative Scenario
  • 3.3. Opportunity Map Analysis
  • 3.4. Product Life Cycle Analysis
  • 3.5. Investment Feasibility Matrix
  • 3.6. PESTLE and Porter's Analysis
  • 3.7. Regulatory Landscape
    • 3.7.1. By Key Regions
    • 3.7.2. By Key Countries
  • 3.8. Regional Parent Market Outlook

4. Global Drug of Abuse Testing Services Market Analysis, 2019-2032

  • 4.1. Historical Market Size Value (US$ Mn) Analysis, 2019-2024
  • 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2025-2032
    • 4.2.1. Y-o-Y Growth Trend Analysis
    • 4.2.2. Absolute $ Opportunity Analysis

5. Global Drug of Abuse Testing Services Market Analysis, 2019-2032, By Drug Type

  • 5.1. Introduction / Key Findings
  • 5.2. Historical Market Size Value (US$ Mn) Analysis By Drug Type, 2019-2024
  • 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Drug Type, 2025-2032
    • 5.3.1. Alcohol
    • 5.3.2. Cannabis/Marijuana
    • 5.3.3. Cocaine
    • 5.3.4. Opioids
    • 5.3.5. Amphetamine & Methamphetamine
    • 5.3.6. LSD
    • 5.3.7. Other Drug Types
  • 5.4. Y-o-Y Growth Trend Analysis By Drug Type, 2019-2024
  • 5.5. Absolute $ Opportunity Analysis By Drug Type, 2025-2032

6. Global Drug of Abuse Testing Services Market Analysis, 2019-2032, By Region

  • 6.1. Introduction
  • 6.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2019-2024
  • 6.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2025-2032
    • 6.3.1. North America
    • 6.3.2. Latin America
    • 6.3.3. Europe
    • 6.3.4. Asia Pacific
    • 6.3.5. Middle East and Africa
  • 6.4. Market Attractiveness Analysis By Region

7. North America Drug of Abuse Testing Services Market Analysis, 2019-2032, By Country

  • 7.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2024
  • 7.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2025-2032
    • 7.2.1. By Country
      • 7.2.1.1. U.S.
      • 7.2.1.2. Canada
    • 7.2.2. By Drug Type
  • 7.3. Market Attractiveness Analysis
    • 7.3.1. By Country
    • 7.3.2. By Drug Type
  • 7.4. Key Takeaways

8. Latin America Drug of Abuse Testing Services Market Analysis, 2019-2032, By Country

  • 8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2024
  • 8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2025-2032
    • 8.2.1. By Country
      • 8.2.1.1. Brazil
      • 8.2.1.2. Mexico
      • 8.2.1.3. Rest of Latin America
    • 8.2.2. By Drug Type
  • 8.3. Market Attractiveness Analysis
    • 8.3.1. By Country
    • 8.3.2. By Drug Type
  • 8.4. Key Takeaways

9. Europe Drug of Abuse Testing Services Market Analysis, 2019-2032, By Country

  • 9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2024
  • 9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2025-2032
    • 9.2.1. By Country
      • 9.2.1.1. Germany
      • 9.2.1.2. U.K.
      • 9.2.1.3. France
      • 9.2.1.4. Spain
      • 9.2.1.5. Italy
      • 9.2.1.6. Russia
      • 9.2.1.7. Rest of Europe
    • 9.2.2. By Drug Type
  • 9.3. Market Attractiveness Analysis
    • 9.3.1. By Country
    • 9.3.2. By Drug Type
  • 9.4. Key Takeaways

10. Asia Pacific Drug of Abuse Testing Services Market Analysis, 2019-2032, By Country

  • 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2024
  • 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2025-2032
    • 10.2.1. By Country
      • 10.2.1.1. China
      • 10.2.1.2. Japan
      • 10.2.1.3. India
      • 10.2.1.4. South Korea
      • 10.2.1.5. Australia
      • 10.2.1.6. Rest of APAC
    • 10.2.2. By Drug Type
  • 10.3. Market Attractiveness Analysis
    • 10.3.1. By Country
    • 10.3.2. By Drug Type
  • 10.4. Key Takeaways

11. Middle East and Africa Drug of Abuse Testing Services Market Analysis, 2019-2032, By Country

  • 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2024
  • 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2025-2032
    • 11.2.1. By Country
      • 11.2.1.1. South Africa
      • 11.2.1.2. Saudi Arabia
      • 11.2.1.3. UAE
      • 11.2.1.4. Israel
      • 11.2.1.5. Rest of MEA
    • 11.2.2. By Drug Type
  • 11.3. Market Attractiveness Analysis
    • 11.3.1. By Country
    • 11.3.2. By Drug Type
  • 11.4. Key Takeaways

12. Key Countries Drug of Abuse Testing Services Market Analysis

  • 12.1. U.S.
    • 12.1.1. Pricing Analysis
    • 12.1.2. Market Share Analysis, 2025
      • 12.1.2.1. By Drug Type
  • 12.2. Canada
    • 12.2.1. Pricing Analysis
    • 12.2.2. Market Share Analysis, 2025
      • 12.2.2.1. By Drug Type
  • 12.3. Brazil
    • 12.3.1. Pricing Analysis
    • 12.3.2. Market Share Analysis, 2025
      • 12.3.2.1. By Drug Type
  • 12.4. Mexico
    • 12.4.1. Pricing Analysis
    • 12.4.2. Market Share Analysis, 2025
      • 12.4.2.1. By Drug Type
  • 12.5. Germany
    • 12.5.1. Pricing Analysis
    • 12.5.2. Market Share Analysis, 2025
      • 12.5.2.1. By Drug Type
  • 12.6. U.K.
    • 12.6.1. Pricing Analysis
    • 12.6.2. Market Share Analysis, 2025
      • 12.6.2.1. By Drug Type
  • 12.7. France
    • 12.7.1. Pricing Analysis
    • 12.7.2. Market Share Analysis, 2025
      • 12.7.2.1. By Drug Type
  • 12.8. Spain
    • 12.8.1. Pricing Analysis
    • 12.8.2. Market Share Analysis, 2025
      • 12.8.2.1. By Drug Type
  • 12.9. Italy
    • 12.9.1. Pricing Analysis
    • 12.9.2. Market Share Analysis, 2025
      • 12.9.2.1. By Drug Type
  • 12.10. Russia
    • 12.10.1. Pricing Analysis
    • 12.10.2. Market Share Analysis, 2025
      • 12.10.2.1. By Drug Type
  • 12.11. China
    • 12.11.1. Pricing Analysis
    • 12.11.2. Market Share Analysis, 2025
      • 12.11.2.1. By Drug Type
  • 12.12. Japan
    • 12.12.1. Pricing Analysis
    • 12.12.2. Market Share Analysis, 2025
      • 12.12.2.1. By Drug Type
  • 12.13. India
    • 12.13.1. Pricing Analysis
    • 12.13.2. Market Share Analysis, 2025
      • 12.13.2.1. By Drug Type
  • 12.14. South Korea
    • 12.14.1. Pricing Analysis
    • 12.14.2. Market Share Analysis, 2025
      • 12.14.2.1. By Drug Type
  • 12.15. Australia
    • 12.15.1. Pricing Analysis
    • 12.15.2. Market Share Analysis, 2025
      • 12.15.2.1. By Drug Type
  • 12.16. South Africa
    • 12.16.1. Pricing Analysis
    • 12.16.2. Market Share Analysis, 2025
      • 12.16.2.1. By Drug Type
  • 12.17. Saudi Arabia
    • 12.17.1. Pricing Analysis
    • 12.17.2. Market Share Analysis, 2025
      • 12.17.2.1. By Drug Type
  • 12.18. UAE
    • 12.18.1. Pricing Analysis
    • 12.18.2. Market Share Analysis, 2025
      • 12.18.2.1. By Drug Type
  • 12.19. Israel
    • 12.19.1. Pricing Analysis
    • 12.19.2. Market Share Analysis, 2025
      • 12.19.2.1. By Drug Type

13. Market Structure Analysis

  • 13.1. Competition Dashboard
  • 13.2. Competition Benchmarking
  • 13.3. Market Share Analysis of Top Players
    • 13.3.1. By Regional
    • 13.3.2. By Drug Type

14. Competition Analysis

  • 14.1. Competition Deep Dive
    • 14.1.1. Quest Diagnostics, Inc.
      • 14.1.1.1. Overview
      • 14.1.1.2. Product Portfolio
      • 14.1.1.3. Profitability by Market Segments
      • 14.1.1.4. Sales Footprint
      • 14.1.1.5. Strategy Overview
        • 14.1.1.5.1. Marketing Strategy
    • 14.1.2. Abbott Laboratories
      • 14.1.2.1. Overview
      • 14.1.2.2. Product Portfolio
      • 14.1.2.3. Profitability by Market Segments
      • 14.1.2.4. Sales Footprint
      • 14.1.2.5. Strategy Overview
        • 14.1.2.5.1. Marketing Strategy
    • 14.1.3. Clinical Reference Laboratory, Inc.
      • 14.1.3.1. Overview
      • 14.1.3.2. Product Portfolio
      • 14.1.3.3. Profitability by Market Segments
      • 14.1.3.4. Sales Footprint
      • 14.1.3.5. Strategy Overview
        • 14.1.3.5.1. Marketing Strategy
    • 14.1.4. Laboratory Corporation of America Holdings
      • 14.1.4.1. Overview
      • 14.1.4.2. Product Portfolio
      • 14.1.4.3. Profitability by Market Segments
      • 14.1.4.4. Sales Footprint
      • 14.1.4.5. Strategy Overview
        • 14.1.4.5.1. Marketing Strategy
    • 14.1.5. Cordant Health Solutions
      • 14.1.5.1. Overview
      • 14.1.5.2. Product Portfolio
      • 14.1.5.3. Profitability by Market Segments
      • 14.1.5.4. Sales Footprint
      • 14.1.5.5. Strategy Overview
        • 14.1.5.5.1. Marketing Strategy
    • 14.1.6. Legacy Medical Services, LLC.
      • 14.1.6.1. Overview
      • 14.1.6.2. Product Portfolio
      • 14.1.6.3. Profitability by Market Segments
      • 14.1.6.4. Sales Footprint
      • 14.1.6.5. Strategy Overview
        • 14.1.6.5.1. Marketing Strategy
    • 14.1.7. DrugScan
      • 14.1.7.1. Overview
      • 14.1.7.2. Product Portfolio
      • 14.1.7.3. Profitability by Market Segments
      • 14.1.7.4. Sales Footprint
      • 14.1.7.5. Strategy Overview
        • 14.1.7.5.1. Marketing Strategy
    • 14.1.8. Omega Laboratories, Inc.
      • 14.1.8.1. Overview
      • 14.1.8.2. Product Portfolio
      • 14.1.8.3. Profitability by Market Segments
      • 14.1.8.4. Sales Footprint
      • 14.1.8.5. Strategy Overview
        • 14.1.8.5.1. Marketing Strategy
    • 14.1.9. Psychemedics Corporation
      • 14.1.9.1. Overview
      • 14.1.9.2. Product Portfolio
      • 14.1.9.3. Profitability by Market Segments
      • 14.1.9.4. Sales Footprint
      • 14.1.9.5. Strategy Overview
        • 14.1.9.5.1. Marketing Strategy
    • 14.1.10. Mayo Clinic Laboratories
      • 14.1.10.1. Overview
      • 14.1.10.2. Product Portfolio
      • 14.1.10.3. Profitability by Market Segments
      • 14.1.10.4. Sales Footprint
      • 14.1.10.5. Strategy Overview
        • 14.1.10.5.1. Marketing Strategy

15. Assumptions & Acronyms Used

16. Research Methodology